As of Aug 28
| -0.09 / -2.39%|
The 1 analysts offering 12-month price forecasts for ContraVir Pharmaceuticals Inc have a median target of 6.80, with a high estimate of 6.80 and a low estimate of 6.80. The median estimate represents a +84.78% increase from the last price of 3.68.
The current consensus among 1 polled investment analysts is to Buy stock in ContraVir Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.